Institute of Oncology Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia.
Technol Cancer Res Treat. 2011 Oct;10(5):475-85. doi: 10.7785/tcrt.2012.500224.
Electrochemotherapy is now in development for treatment of deep-seated tumors, like in bones and internal organs, such as liver. The technology is available with a newly developed electric pulse generator and long needle electrodes; however the procedures for the treatment are not standardized yet. In order to describe the treatment procedure, including treatment planning, within the ongoing clinical study, a case of successful treatment of a solitary metastasis in the liver of colorectal cancer is presented. The procedure was performed intraoperatively by inserting long needle electrodes, two in the center of the tumor and four around the tumor into the normal tissue. The insertion of electrodes proved to be feasible and was done according to the treatment plan, prepared by numerical modeling. After intravenous bolus injection of bleomycin the tumor was exposed to electric pulses. The delivery of the electric pulses did not interfere with functioning of the heart, since the pulses were synchronized with electrocardiogram in order to be delivered outside the vulnerable period of the ventricles. Also the post treatment period was uneventful without side effects. Re-operation of the treated metastasis demonstrated feasibility of the reoperation, without secondary effects of electrochemotherapy on normal tissue. Good antitumor effectiveness with complete tumor destruction was confirmed with histological analysis. The patient is disease-free 16 months after the procedure. In conclusion, treatment procedure for electrochemotherapy proved to be a feasible technological approach for treatment of liver metastasis. Due to the absence of the side effects and the first complete destruction of the treated tumor, treatment procedure for electrochemotherapy seems to be a safe method for treatment of liver metastases with good treatment effectiveness even in difficult-to-reach locations.
电化学疗法目前正在开发中,用于治疗深部肿瘤,如骨骼和内部器官,如肝脏。该技术可与新开发的电脉冲发生器和长针电极一起使用;然而,治疗程序尚未标准化。为了描述正在进行的临床研究中的治疗过程,包括治疗计划,本文呈现了一例成功治疗结直肠癌肝脏单发转移的病例。该手术通过插入长针电极进行,将两个电极插入肿瘤中心,四个电极插入肿瘤周围的正常组织中。电极的插入被证明是可行的,并且是按照数值建模准备的治疗计划进行的。在静脉注射博来霉素后,肿瘤暴露于电脉冲下。由于电脉冲与心电图同步,以便在心室易损期之外释放,因此电脉冲的传递不会干扰心脏功能。此外,治疗后期间没有出现并发症,也没有副作用。对治疗的转移灶进行再次手术证明了再次手术的可行性,电化学疗法对正常组织没有二次影响。组织学分析证实了良好的抗肿瘤效果和完全的肿瘤破坏。该患者在手术后 16 个月无病生存。总之,电化学疗法的治疗过程被证明是一种可行的治疗肝脏转移的技术方法。由于没有副作用,并且首次完全破坏了治疗的肿瘤,电化学疗法的治疗过程似乎是一种安全的方法,用于治疗肝脏转移,即使在难以到达的部位,也具有良好的治疗效果。